Status:

RECRUITING

Eye Movement Desensitization and Reprocessing (EMDR) as a Treatment for Chronic Painful Diabetic Peripheral Neuropathy

Lead Sponsor:

Dijklander Ziekenhuis

Conditions:

Neuropathic Pain

Diabetes Mellitus

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The goal of this clinical trial is to investigate the effectiveness of Eye Movement Desensitization and Reprocessing (EMDR) therapy in reducing pain intensity in individuals with chronic painful diabe...

Detailed Description

The study adopts a single-case experimental design, replicated nine times (N-of-1 study). Research on the effectiveness of EMDR therapy for neuropathic pain is limited to studies on phantom pain (and...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Age: ≥ 18 years.
  • Diagnosis of Diabetes Mellitus.
  • Severity of pain in the past month, NRS-pain score ≥ 6.
  • Ability to communicate in both written and spoken Dutch.
  • Willingness to participate in the study (signed informed consent (IC)).
  • Exclusion criteria:
  • Severe psychiatric disorders requiring immediate treatment.
  • IQ \< 80.
  • Initiation of medication within 3 months before the start of the study (medication in use for more than 3 months can be maintained; discontinuation of medication during the study is possible but not desirable).
  • Concurrent psychotherapeutic treatment targeting neuropathic pain during the study.
  • Substance abuse and/or dependence, unless medically prescribed.
  • Inability to complete the questionnaires.
  • Co-morbid conditions affecting the lower extremities, such as peripheral arterial disease, severe rheumatoid arthritis, osteoarthritis. Other conditions causing pain in the feet and/or damage to the peripheral nervous system, for example, ulcers.
  • Co-morbid chronic pain syndromes.

Exclusion

    Key Trial Info

    Start Date :

    March 1 2024

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    March 31 2025

    Estimated Enrollment :

    10 Patients enrolled

    Trial Details

    Trial ID

    NCT06171230

    Start Date

    March 1 2024

    End Date

    March 31 2025

    Last Update

    March 12 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Dijklander Ziekenhuis

    Hoorn, Netherlands, 1624 NP